Functionalization of Biomaterials


Article Preview

In order to improve the tissue integration and subsequently the long-term maintenance, the implant surface can be modified by mechanical, physical, chemical or biological functionalization. In this way, the surface becomes biologically active by further grafting of biomolecules. Two principal concepts are considered for materials functionalization. (i) The Drug Delivery Systems (DDS) where the bioactive molecules goes to the target. (ii) The grafting of the bioactive compounds on small strongly bound spacer molecules. In this system, the target goes to the bioactive molecules. These techniques provide promising outlooks for any polymeric or ceramic scaffold used in tissue engineering for the construction of whole artificial and functional organs.



Key Engineering Materials (Volumes 288-289)

Edited by:

Xingdong Zhang, Junzo Tanaka, Yaoting Yu and Yasuhiko Tabata




H.F. Hildebrand et al., "Functionalization of Biomaterials", Key Engineering Materials, Vols. 288-289, pp. 47-50, 2005

Online since:

June 2005




[1] P. Linez-Bataillon, F. Monchau, M. Bigerelle and H.F. Hildebrand: Biomol Engineering 2002, 19, 133- 142.

[2] E. Eisenbarth, J Meyle, W Nachtigall and J Breme: Biomaterials 1996, 17, 1399-1403.

[3] J. Breme, E. Eisenbarth and H.F. Hildebrand: Calcium Phosphate Materials - Fundamentals, Saurampsmédical, Montpellier, (ISBN: 2-84023-173-5) 1998, pp.139-151.

[4] Y.M. Zhang, P. Bataillon-Linez, P. Huang, Y.M. Zhao, Y. Han, M. Traisnel, K.W. Xu and H.F. Hildebrand: J Biomed Mater Res 2004, 68A, 383-291.


[5] C. Dupas-Bruzek, L. D Laude and C. Dicara: Appl. Surface Science 2002, 186, 124-129.

[6] C. Dupas-Bruzek, L. D Laude, F. Langenhorst and K. Kolev: J. Appl. Physics 2003, 93, 4489-4496.

[7] D.H. Kaelble and J. Moacanin: Polymer 1977, 18, 475-482.

[8] S.A. Redey, M. Nardin, D. Bernache-Assolant, C. Rey, P. Delannoy, L. Sedel and P.J. Marie: J Biomed Mater Res 2000, 50, 353-364.


[9] M. Lampin, R. Warocquier-Clerout, C. Legris, M. Degrange and M.F. Sigot-Luizard: J Biomed Mater Res 1997, 36, 99-108.


[10] E. Eisenbarth, P. Linez, V. Biehl, D. Velten, J. Breme, H.F. Hildebrand: Biomol Engineering 2002, 19, 233-238.


[11] S. Hatton, J.D. Andrade, J.B. Hibbs Jr, D.E. Gregonis and R.N. King: J Colloid Interface Sci 1985, 104, 73-81.

[12] H.F. Hildebrand, Ph. Rocher, F. Monchau and E. Delcourt-Debruyne: Biomaterialien, 2002, 3, 14-20.

[13] H. Petite, V. Frei, A. Huc and D. Herbage: J Biomed Mat Res 1994, 28, 159-165.

[14] M. Weltrowski, M. Morcellet and B. Martel: patent FR 99/01967 (1999) - PCT/FR00/00378(2000) - US 09 913, 448 (2001).

[15] B. Martel, M. Morcellet and M. Weltrowski patent PCT/FR00/00377 (2000) - US 09/913, 475 (2001).

[16] B. Martel, M. Morcellet, D. Ruffin, L. Ducoroy and M Weltrowski: J. Incl. Phen. Macr. Chem. 2002, 44, 443-446. 17. O. Melnyk, X. Duburcq, C. Olivier, F. Urbès, C. Auriault and H. Gras-Masse: Bioconjug. Chem., 2002, 13, 713-720.


[18] F. Urbès, J. -S. Fruchart, H. Gras-Masse and O. Melnyk: Letters in Peptide Science, 2002, 8, 253-258.